Internal Medicine, Hematology & Oncology · Jacksonville, FL
NPI
1508908328
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
4500 San Pablo Rd S
Jacksonville, FL, 32224
Phone (904) 953-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
11,351 services
Medicare patients, 2024
235
Average age 72
Drug cost, 2024
$1.9M
820 prescriptions
Company payments, 2025
$14K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saranya Chumsri was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 112 times for 11 patients. In total Saranya Chumsri billed 11,351 services in 74 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 112 | 11 | $0.09 | $10.19 |
| 99215 Office E&M - Established | Office | 111 | 84 | $132.70 | $15K |
| 99214 Office E&M - Established | Office | 97 | 81 | $90.25 | $8,754 |
| 99213 Office E&M - Established | Office | 65 | 54 | $64.53 | $4,195 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 49 | 35 | $12.55 | $615 |
| 96375 Injection Administration | Office | 32 | 14 | $11.54 | $369 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 30 | 21 | $25.41 | $762 |
| 99212 Office E&M - Established | Office | 20 | 19 | $40.92 | $818 |
| 99421 Office/Outpatient Services | Office | 20 | 17 | $11.09 | $222 |
| 96372 Injection Administration | Office | 15 | 13 | $10.96 | $164 |
| 96413 Chemotherapy Administration | Office | 14 | 14 | $96.47 | $1,351 |
| 36591 Vascular | Office | 12 | 11 | $20.45 | $245 |
By year: 2022 $801K for 40,843 services; 2023 $129K for 9,145 services; 2024 $136K for 11,351 services.
Medicare prescription drug claims, 2024
In 2024, the drug Saranya Chumsri prescribed most often to Medicare patients was Letrozole, with 207 prescriptions and refills. In total Saranya Chumsri wrote 820 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 207 | 575 | 75 | $5,172 |
| Anastrozole Generic | 77 | 205 | 31 | $1,589 |
| Verzenio Abemaciclib | 54 | 54 | Under 11 | $838K |
| Exemestane Generic | 30 | 82 | 15 | $4,071 |
| Oxycodone Hcl Generic | 28 | 28 | Under 11 | $499 |
| Ibandronate Sodium Generic | 24 | 71 | 14 | $906 |
| Kisqali Ribociclib Succinate | 23 | 23 | Under 11 | $314K |
| Ondansetron Hcl Generic | 19 | 19 | 13 | $241 |
| Tukysa Tucatinib | 17 | 17 | Under 11 | $399K |
| Prochlorperazine Maleate Generic | 14 | 14 | 12 | $241 |
| Gabapentin Generic | 14 | 30 | Under 11 | $110 |
| Eliquis Apixaban | 13 | 17 | Under 11 | $9,565 |
| Lorazepam Generic | 13 | 15 | Under 11 | $50.72 |
| Dexamethasone Generic | 13 | 13 | Under 11 | $375 |
| Tamoxifen Citrate Generic | 13 | 37 | Under 11 | $293 |
Brand drugs: 154 claims; generic drugs: 666 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saranya Chumsri $14K ($14K in general payments such as food, travel and fees) from 12 companies. The largest payer was Merck Sharp & Dohme LLC with $7,953.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 4 | $7,953 |
| Stemline Therapeutics Inc. | 2 | $2,777 |
| Pfizer Inc. PFE | 1 | $945 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $863 |
| Gilead Sciences, Inc. GILD | 1 | $580 |
| Caris MPI, Inc. | 3 | $412 |
| Boston Scientific Corporation BSX | 1 | $122 |
| Lilly USA, LLC LLY | 1 | $79.44 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $68.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.